Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)
Open Access
- 1 July 2017
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 19 (7) , 402-409
Abstract
Background: In a previous study we demonstrated improvement in metabolic control and reduction in hypoglycemia in people with type 1 diabetes on multiple daily injections, after having used a bolus calculator for 4 months. Objective: To demonstrate whether (1) extending its use (2) or introducing it in the control group, previously subjected to treatment intensification, could further improve metabolic control and related psychological issues. Methods: After the previous clinical trial, in which the subjects were randomized either to treatment with the calculator or to control group for 4 months, both groups used the calculator during an additional 4-month period. Results: In the previous control group, after using the device, HbA1c did not improve (7.86% ± 0.87% vs. 8.01% ± 0.93%, P 0.215), although a significant decrease in postprandial hypoglycemia was observed (2.3 ± 2 vs. 1.1 ± 1.2/2 weeks, P 0.002). In the group in which the treatment was extended from 4 to 8 months, HbA1c did not improve either (7.61 ± 0.58 vs. 7.73 ± 0.65, P 0.209); however this group had a greater perceived treatment satisfaction (12.03 ± 4.26 vs. 13.71 ± 3.75, P 0.007) and a significant decrease in fear of hypoglycemia (28.24 ± 8.18 basal vs. 25.66 ± 8.02 at 8 months, P 0.026). Conclusions: The extension in the use of the calculator or its introduction in a previously intensified control group did not improve metabolic control, although it did confirm a decrease in hypoglycemic episodes in the short term, while the extension of its use to 8 months was associated with a reduction in fear of hypoglycemia and greater treatment satisfaction.Keywords
This publication has 20 references indexed in Scilit:
- ProAct Study: New Features of Insulin Pumps Improve Diabetes Management and Glycemic Control in Patients after Transition of Continuous Subcutaneous Insulin Infusion SystemsDiabetes Technology & Therapeutics, 2013
- Use of Microneedle Array Devices for Continuous Glucose Monitoring: A ReviewDiabetes Technology & Therapeutics, 2013
- Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]BMC Family Practice, 2012
- Use of an Automated Bolus Calculator in MDI-Treated Type 1 DiabetesDiabetes Care, 2012
- Many patients with Type 1 diabetes estimate their prandial insulin need inappropriatelyJournal of Diabetes, 2010
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusCochrane Database of Systematic Reviews, 2010
- Bolus Calculator: A Review of Four “Smart” Insulin PumpsDiabetes Technology & Therapeutics, 2008
- Clinical Usefulness of a Bolus Calculator in Maintaining Normoglycaemia in Active Professional Patients with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin InfusionJournal of International Medical Research, 2008
- Benefits of a bolus calculator in pre‐ and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII)Diabetic Medicine, 2008
- A Bolus Calculator Is an Effective Means of Controlling Postprandial Glycemia in Patients on Insulin Pump TherapyDiabetes Technology & Therapeutics, 2003